Compare WVE & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | BFST |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.7M | 1.0B |
| IPO Year | 2015 | 2014 |
| Metric | WVE | BFST |
|---|---|---|
| Price | $4.89 | $31.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | $29.81 | ★ $32.75 |
| AVG Volume (30 Days) | ★ 3.4M | 163.1K |
| Earning Date | 04-28-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | N/A | ★ 23.45 |
| EPS | N/A | ★ 1.37 |
| Revenue | $3,704,000.00 | ★ $10,704,000.00 |
| Revenue This Year | N/A | $22.71 |
| Revenue Next Year | $85.67 | $5.02 |
| P/E Ratio | ★ N/A | $23.24 |
| Revenue Growth | ★ 149.43 | 1.20 |
| 52 Week Low | $4.65 | $22.56 |
| 52 Week High | $21.73 | $32.53 |
| Indicator | WVE | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 51.44 |
| Support Level | N/A | $31.26 |
| Resistance Level | $6.33 | $31.49 |
| Average True Range (ATR) | 0.23 | 0.46 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 22.03 | 59.73 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.